• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎中的凝血与炎症:炎症标志物与凝血标志物之间的相互关系。

Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.

机构信息

Division of Laboratory Hematology and Blood Banking, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Ann Hematol. 2024 Jun;103(6):1819-1831. doi: 10.1007/s00277-024-05630-1. Epub 2024 Feb 13.

DOI:10.1007/s00277-024-05630-1
PMID:38349409
Abstract

The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), formerly known as 2019-nCoV. Numerous cellular and biochemical issues arise after COVID-19 infection. The severe inflammation that is caused by a number of cytokines appears to be one of the key hallmarks of COVID-19. Additionally, people with severe COVID-19 have coagulopathy and fulminant thrombotic events. We briefly reviewed the COVID-19 disease at the beginning of this paper. The inflammation and coagulation markers and their alterations in COVID-19 illness are briefly discussed in the parts that follow. Next, we talked about NETosis, which is a crucial relationship between coagulation and inflammation. In the end, we mentioned the two-way relationship between inflammation and coagulation, as well as the factors involved in it. We suggest that inflammation and coagulation are integrated systems in COVID-19 that act on each other in such a way that not only inflammation can activate coagulation but also coagulation can activate inflammation.

摘要

新型冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的,以前称为 2019-nCoV。COVID-19 感染后会出现许多细胞和生化问题。大量细胞因子引起的严重炎症似乎是 COVID-19 的关键特征之一。此外,重症 COVID-19 患者存在凝血功能障碍和暴发性血栓事件。本文首先简要回顾了 COVID-19 疾病。接下来的部分简要讨论了 COVID-19 疾病中的炎症和凝血标志物及其变化。接下来,我们讨论了 NETosis,这是凝血和炎症之间的关键关系。最后,我们提到了炎症和凝血之间的双向关系,以及其中涉及的因素。我们认为炎症和凝血是 COVID-19 中的整合系统,它们以相互作用的方式发挥作用,不仅炎症可以激活凝血,而且凝血也可以激活炎症。

相似文献

1
Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.新型冠状病毒肺炎中的凝血与炎症:炎症标志物与凝血标志物之间的相互关系。
Ann Hematol. 2024 Jun;103(6):1819-1831. doi: 10.1007/s00277-024-05630-1. Epub 2024 Feb 13.
2
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.中性粒细胞胞外诱捕网的循环标志物对COVID-19患者具有预后价值。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994. doi: 10.1161/ATVBAHA.120.315267. Epub 2020 Dec 3.
3
The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.PI3K/AKT 信号通路在 SARS-CoV-2 诱导的凝血功能障碍中的可能作用和治疗潜力。
Cell Mol Biol Lett. 2022 Jan 11;27(1):6. doi: 10.1186/s11658-022-00308-w.
4
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.血小板病和血管内皮病:COVID-19 血栓炎症的重要促成因素。
Nat Rev Cardiol. 2021 Mar;18(3):194-209. doi: 10.1038/s41569-020-00469-1. Epub 2020 Nov 19.
5
Major coagulation disorders and parameters in COVID-19 patients.COVID-19 患者的主要凝血障碍和参数。
Eur J Med Res. 2022 Feb 15;27(1):25. doi: 10.1186/s40001-022-00655-6.
6
The most important biomarker associated with coagulation and inflammation among COVID-19 patients.与 COVID-19 患者凝血和炎症相关的最重要的生物标志物。
Mol Cell Biochem. 2021 Jul;476(7):2877-2885. doi: 10.1007/s11010-021-04122-4. Epub 2021 Mar 19.
7
Haematological manifestations of COVID-19: From cytopenia to coagulopathy.COVID-19 的血液学表现:从细胞减少症到凝血障碍。
Eur J Haematol. 2020 Nov;105(5):540-546. doi: 10.1111/ejh.13491. Epub 2020 Aug 31.
8
A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.特定的低密度中性粒细胞群体与住院 COVID-19 患者的高凝状态和疾病严重程度相关。
JCI Insight. 2021 May 10;6(9):148435. doi: 10.1172/jci.insight.148435.
9
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses.新型冠状病毒和其他大流行病毒感染患者的凝血异常和血栓形成。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2033-2044. doi: 10.1161/ATVBAHA.120.314514. Epub 2020 Jul 13.
10
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.新型冠状病毒病和 SARS-CoV-2 疫苗接种中的凝血障碍和纤维蛋白溶解病理生理学。
Int J Mol Sci. 2022 Mar 19;23(6):3338. doi: 10.3390/ijms23063338.

引用本文的文献

1
Deep vein thrombosis in severe community-acquired pneumonia patients undergoing thromboprophylaxis: Prevalence, risk factors, and outcome.接受血栓预防的重症社区获得性肺炎患者的深静脉血栓形成:患病率、危险因素及结局
Thromb J. 2025 Mar 12;23(1):23. doi: 10.1186/s12959-025-00706-y.
2
Erbin Regulates Tissue Factors Through Ras/Raf Pathway in Coagulation Disorders in Sepsis.埃尔宾通过Ras/Raf途径调节脓毒症凝血障碍中的组织因子。
J Inflamm Res. 2025 Feb 5;18:1739-1754. doi: 10.2147/JIR.S493093. eCollection 2025.
3
Incidence of seroma and postoperative complications after breast surgery before and during the Covid-19 pandemic: results from a retrospective multicenter analysis.

本文引用的文献

1
High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis.COVID-19 中高水平的血管性血友病因子标志物:一项系统评价和荟萃分析。
Clin Exp Med. 2022 Aug;22(3):347-357. doi: 10.1007/s10238-021-00769-x. Epub 2021 Nov 6.
2
Relationships of the neutrophil-lymphocyte and CRP-albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19.中性粒细胞与淋巴细胞比值和 C 反应蛋白与白蛋白比值与 COVID-19 老年患者住院时间和病死率的关系。
J Int Med Res. 2021 Sep;49(9):3000605211046112. doi: 10.1177/03000605211046112.
3
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19.
新冠疫情之前及期间乳腺癌手术后血清肿及术后并发症的发生率:一项回顾性多中心分析结果
BMC Cancer. 2025 Jan 15;25(1):91. doi: 10.1186/s12885-025-13425-4.
4
Superficial Vein Thrombosis in an Asymptomatic Case of Cholangiocarcinoma with Recent History of COVID-19.近期有新冠病毒病病史的无症状胆管癌患者并发浅静脉血栓形成
Life (Basel). 2024 Aug 30;14(9):1095. doi: 10.3390/life14091095.
降钙素原在抗生素个体化治疗中的应用:更新及在 COVID-19 中的重点关注。
Crit Rev Clin Lab Sci. 2022 Jan;59(1):54-65. doi: 10.1080/10408363.2021.1975637. Epub 2021 Sep 13.
4
Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19.C 反应蛋白/白蛋白比值对 COVID-19 患者是否具有预后价值。
J Infect Dev Ctries. 2021 Aug 31;15(8):1086-1093. doi: 10.3855/jidc.14826.
5
Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study.2型糖尿病患者中C反应蛋白与血清白蛋白比值与糖尿病肾病相关吗?CARE TIME研究。
Prim Care Diabetes. 2021 Dec;15(6):1071-1074. doi: 10.1016/j.pcd.2021.08.015. Epub 2021 Sep 6.
6
Inflammation in COVID-19: from pathogenesis to treatment.新型冠状病毒肺炎中的炎症:从发病机制到治疗
Int J Clin Exp Pathol. 2021 Jul 15;14(7):831-844. eCollection 2021.
7
Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.巴基斯坦 SARS-COV-2 感染患者的血液学和生化学参数作为诊断和预后标志物:一项回顾性比较分析。
Hematology. 2021 Dec;26(1):529-542. doi: 10.1080/16078454.2021.1950898.
8
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.组织因子上调与 COVID-19 患者肺部的 SARS-CoV-2 有关。
J Thromb Haemost. 2021 Sep;19(9):2268-2274. doi: 10.1111/jth.15451. Epub 2021 Jul 18.
9
Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19.入院时蛋白C水平较低是新冠肺炎住院患者疾病恶化和死亡的一个危险因素。
Thromb Res. 2021 Aug;204:13-15. doi: 10.1016/j.thromres.2021.05.016. Epub 2021 May 29.
10
IL-33 in COVID-19: friend or foe?白细胞介素-33在新型冠状病毒肺炎中:是友还是敌?
Cell Mol Immunol. 2021 Jun;18(6):1602-1604. doi: 10.1038/s41423-021-00685-w. Epub 2021 May 10.